Results 81 to 90 of about 137,432 (267)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Childhood aplastic anemia (AA) is a rare disease, and both the disease itself and its treatment cause significant morbidity. We aimed to determine the contemporary incidence of childhood AA in Finland, to compare the clinical characteristics of AA against inherited bone marrow failure syndromes (IBMFS) and refractory cytopenia of ...
Lauri‐Matti Kulmala +8 more
wiley +1 more source
St Andrews Encyclopaedia of Theology, 2022 Though not linguistically prominent in Christian scripture, the theology of providence captures several recurring scriptural themes. These include the order of the cosmos, the wisdom reflected in the natural and social worlds, the direction of the ...
David Fergusson
doaj
Causation and complications [PDF]
Indian Journal of Plastic Surgery, 2010 hese are the facts that the authors presented: 1. The patient developed his infection eight weeks after his injections. 2. Despite having an infection that required drainage, the patient had normal range of motion in his metacarpophalangeal joints. 3. The patient refused to be admitted to hospital for “surgical drainage under general anesthesia”, hence,
openaire +4 more sources
The Role of Chemotherapy in Pediatric Myoepithelial Carcinoma: A Systematic Review of the Literature
Pediatric Blood &Cancer, EarlyView.ABSTRACT Myoepithelial carcinoma (MEC) in pediatric patients is a rare and aggressive malignancy characterized by heterogeneous morphology and variable molecular features. The optimal role of chemotherapy remains unclear. We conducted a systematic review according to PRISMA 2020 guidelines to evaluate chemotherapy in pediatric and young‐adult patients ...
Marco Salvi +7 more
wiley +1 more source
Determining Parental Factors for Clinical Trial Attrition in Pediatric Acute Lymphoblastic Leukemia
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background/Objectives Despite high enrollment rates on Children's Oncology Group (COG) protocols, attrition after initial consent is challenging, introducing bias and prolonging trial completion. While adult oncology literature has identified predictors of withdrawal, little is known about caregiver decision‐making for child participation in ...
Kimberly L. Stathas +3 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Blinatumomab, a CD19xCD3 bispecific T‐cell engager, has become standard therapy for children with de novo B‐cell acute lymphoblastic leukemia (B‐ALL). This retrospective review describes the experience of blinatumomab administration in pediatric patients.
Julia M. Hurley +6 more
wiley +1 more source
, 2020 People use varied language to express their causal understand-ing of the world. But how does that language map onto peo-ple’s underlying representations, and how do people choosebetween competing ways to best describe what happened? Inthis paper we develop a model that integrates computationaltools for causal judgment and pragmatic inference to ...
Beller, Ari +2 more
openaire +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT We report a retrospective single‐center analysis of pediatric patients with relapsed or refractory B‐cell precursor acute lymphoblastic leukemia focusing on relapses outside of the typical locations, bone marrow, central nervous system, or testes.
Johanna Kunz +7 more
wiley +1 more source